• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Potential New Treatment For Alcohol Use Disorder Identified By Scientists

December 2, 2022 by Deborah Bloomfield

A medication primarily prescribed for heart problems has shown promise as a treatment for alcohol use disorder (AUD). Combining data from animal experiments with observations in humans, the authors of a new study found that the drug spironolactone reduces drinking in multiple species, with the greatest effects seen in alcohol-dependent individuals.

Inspiration for the study came from previous research that highlighted the role of a hormone called aldosterone in alcoholism. Among people with AUD, higher aldosterone levels have been associated with anxiety, obsessive cravings, alcohol withdrawal, and increased drinking.

Advertisement

Though the mechanism behind this effect is unclear, it’s thought that aldosterone enhances mineralocorticoid receptor signaling, thereby altering the body’s ability to regulate fluid and electrolyte levels. Interestingly, spironolactone is known to block mineralocorticoid receptors, and is administered to counteract the effects of aldosterone and treat fluid build-up following heart failure.

To investigate whether spironolactone also helps to alleviate the symptoms of AUD, the researchers administered the drug to alcohol-dependent mice and rats. A dose-dependent effect was observed in both species, whereby the more spironolactone an animal received, the less they drank.

Experiments in mice also looked at the ability of spironolactone to attenuate binge drinking. Compared to rodents exposed to unsweetened alcohol, those that were given sugary alcoholic drinks tended to gorge themselves, achieving blood alcohol levels that are typically seen following intense drinking sessions.

Advertisement

Encouragingly, spironolactone helped these mice to curtail their boozing but didn’t alter their general food and water intake or decrease their appetite for non-alcoholic sugary drinks.

Turning their attention to humans, the researchers analyzed data from the US Veterans Affairs healthcare system to look for changes in alcohol use amongst those who were prescribed spironolactone for a minimum of 60 continuous days. In total, the study authors compared 10,726 spironolactone-exposed individuals to 34,461 unexposed controls, with highly encouraging results.

Using the Alcohol Use Disorders Identification Test-Consumption (AUDIT-C) scale to assess drinking levels, the researchers found that, on average, alcohol intake scores decreased by an extra 0.17 points among those who received the medication. Once again, this effect was found to be dose-dependent, with larger measures of spironolactone correlating with greater decreases in drinking.

Advertisement

Even more importantly, individuals who drank the most at baseline showed the greatest reductions in booze intake. Typically, those who were classed as heavy or hazardous drinkers prior to taking spironolactone achieved a decrease of 0.47 points more than unexposed individuals after treatment.

“Combining findings across three species and different types of research studies, and then seeing similarities in those data, gives us confidence that we are onto something potentially important scientifically and clinically,” explained study author Lorenzo Leggio in a statement. “These findings support further study of spironolactone as a potential treatment for alcohol use disorder, a medical condition that affects millions of people in the US.”

The study has been published in the journal Molecular Psychiatry.

Deborah Bloomfield
Deborah Bloomfield

Related posts:

  1. In 1929 letter, Churchill ponders ‘pleasing and profitable’ pursuits outside politics
  2. China to Wall Street: regulatory crackdown not aimed at restricting private firms
  3. U.S. envoy presses Sudan to move toward civilian rule
  4. Largest Atomic Gas Structure Around Galaxy Group Discovered By Chinese Telescope

Source Link: Potential New Treatment For Alcohol Use Disorder Identified By Scientists

Filed Under: News

Primary Sidebar

  • If We Found Life On Mars, What Would That Mean For The Fermi Paradox And The Great Filter?
  • The Longest Living Mammals Are Giants That Live Up To 200 Years In The Icy Arctic
  • Entirely New Virus Detected In Bat Urine, And It’s Only The 4th Of Its Kind Ever Isolated
  • The First Ever Full Asteroid History: From Its Doomed Discovery To Collecting Its Meteorites
  • World’s Oldest Pachycephalosaur Fossil Pushes Back These Dinosaurs’ Emergence By 15 Million Years
  • The Hole In The Ozone Layer Is Healing And On Track For Full Recovery In The 21st Century, Thanks To Science
  • First Sweet Potato Genome Reveals They’re Hybrids With A Puzzling Past And 6 Sets Of Chromosomes
  • Why Is The Top Of Canada So Sparsely Populated? Meet The “Canadian Shield”
  • Humans Are In The Middle Of “A Great Evolutionary Transition”, New Paper Claims
  • Why Do Some Toilets Have Two Flush Buttons?
  • 130-Year-Old Butter Additive Discovered In Danish Basement Contains Bacteria From The 1890s
  • Prehistoric Humans Made Necklaces From Marine Mollusk Fossils 20,000 Years Ago
  • Zond 5: In 1968 Two Soviet Steppe Tortoises Beat Humans To Orbiting Around The Moon
  • Why Cats Adapted This Defense Mechanism From Snakes
  • Mother Orca Seen Carrying Dead Calf Once Again On Washington Coast
  • A Busy Spider Season Is Brewing: Why This Fall Could See A Boom Of Arachnid Activity
  • What Alternatives Are There To The Big Bang Model?
  • Magnetic Flip Seen Around First Photographed Black Hole Pushes “Models To The Limit”
  • Something Out Of Nothing: New Approach Mimics Matter Creation Using Superfluid Helium
  • Surströmming: Why Sweden’s Stinky Fermented Fish Smells So Bad (But People Still Eat It)
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version